Over the last several weeks, we have been diving deep into what a post-COVID world looks like for the U.S. Medical Economy. In the previous two installments of this three part analysis, we explored the macro drivers of change and their implications at the subsector level in the Post-COVID era. Watch Dec. 9 here; Dec. 15th here. Rough transcipt for Dec. 15th here.
Today, Tom Tobin and I paired up the macro policy changes with the Hedgeye Health Care Microquad analysis. (If you wish to understand how Tom develops and uses Microquads, watch a replay of a talk he gave today here.) Major topics and timstamps below.
|
Timestamps: 0.00 - 3:07 Introduction 3:08 - 11:55 Tom's intro to Microquads 11:56 - 15:00 $JNJ 15:10 - 15:28 $TXG 15:29 - 16:55 $ILMN 16:55 - 17:37 Managed Care 17:38 - 18:24 $UNH 18:24 - 19:29 HUM and ANTM 19:30 - 20:41 $USPH 20:41 - 21:49 $MD 21:50 - 23:55 Macro policy drivers for services & facilities 23:56 - 28:34 Labs: cash positions, capacity expansion and technology advances 28:35 - 29:22 Deregulation and $USPH 29:23 - 31:48 Labor disruption, need for productivity $HCA, $THC 31:49 - 35:38 Managed Care macro policy drivers 35:39 - 42:00 Life Sciences macro drivers of change $ILMN, $TXG 42:00 Q & A: $JNJ: hospital capex, increasing throughput, $SYK: pricing power with ASC, $LH, $DGX: risk of lab concentration to health system, deregulation of CLIA labs; When will the pandemic be over?; managed care left out of relief; spead of vaccine deployment; timing of policy making way into forward estimates. |
Call with questions. I plan on doing loads of needlepoint for New Year's Eve. Interruptions welcome.
Emily Evans
Managing Director – Health Policy
Twitter
LinkedIn
Thomas Tobin
Managing Director - Health Care
Twitter
LinkedIn
